Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Apr 2020 for Yarrow Bioscience, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Anthony D. Bruno: trading record in brief
Filings by Anthony D. Bruno span 2 companies, the busiest being Foamix Pharmaceuticals Ltd. and Yarrow Bioscience, Inc. In total, 8 filings cover trades dated from 16 May 2019 to 3 April 2020.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 7 April 2020: a share grant, in Yarrow Bioscience, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Anthony D. Bruno
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
75,690 sharesCommon StockSEC:0001209191-20-023803:0
14,933 sharesCommon StockSEC:0001209191-20-023803:1
37,112 sharesCommon StockSEC:0001209191-20-018223:0
7,321 sharesCommon StockSEC:0001209191-20-018223:1
62,647 sharesOrdinary SharesSEC:0001209191-20-018193:0
12,360 sharesOrdinary SharesSEC:0001209191-20-018193:1
5,312 shares0Ordinary SharesSEC:0001209191-20-015193:0
28,195 shares0Ordinary SharesSEC:0001209191-19-031534:0
8 of 8 declarations
